Health Insurance Type and Lung Cancer Stage Shift Following Coverage of Screening
Health Services Research · 2026
DOI: 10.1111/1475-6773.70154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Services Research, 2026. Verfasst von Min Lian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Medicine & Geriatrics, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Insurance Coverage, Insurance, Health, Early Detection of Cancer. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS, NCI NIH HHS, JG CDC HHS.
Abstract (Originalsprache)
Objective
To examine the role of insurance coverage of lung cancer screening in driving shifts in lung cancer stage at diagnosis. Study Setting and Design We performed difference‐in‐differences (DID) analyses to compare changes in the proportion of early‐stage lung cancer diagnosis between pre‐coverage (2007–2014) and post‐coverage (2015–2019) periods across insurance groups. Data Sources and Analytic Sample Using the National Cancer Institute's Surveillance, Epidemiology, and End Results database, we identified patients with non‐small cell lung cancer aged 55–77 years and diagnosed between 2007 and 2019. Health insurance at diagnosis was categorized as private, Medicare (fee‐for‐service [FFS], FFS with supplemental private coverage, FFS with Medicaid, and Medicare Advantage with and without Medicaid), Medicaid (FFS and managed care), military health plans, and uninsured. Principal Findings Among 227,112 patients, 63,676 (28.04%) had private insurance, 130,770 (57.58%) Medicare, 14,982 (6.60%) Medicaid, 5941 (2.62%) military health insurance, and 11,743 (5.17%) were uninsured. Compared with uninsured patients, a significantly greater increase in the proportion of early‐stage lung cancer diagnosis between pre‐coverage and post‐coverage periods was observed among Medicaid patients (DID = 2.88 percentage points [ppt], 95% CI 0.73–5.02 ppt), but not patients with private insurance, Medicare, or military health insurance. Among Medicaid beneficiaries, those in managed care showed a significantly greater shift compared with those in FFS during 4–5 years post‐coverage (DID = 8.22 ppt, 95% CI 4.51–11.93 ppt). Among Medicare FFS beneficiaries, dual enrollment in Medicaid was associated with a significantly smaller increase in the proportion of early‐stage diagnosis compared with FFS‐only enrollment during 4–5 years post‐coverage (DID = −4.40 ppt, 95% CI [−6.40]–[−2.40] ppt).
Conclusions
The results suggest that beneficial stage shifts following the recommendation for lung cancer screening varied by health insurance status and type. Addressing patient, provider, and system‐level barriers to lung cancer screening and downstream care is essential to translate lung cancer screening coverage into earlier‐stage diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of General Medicine & Geriatrics, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
- Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.
- School of Public Health, Washington University, St. Louis, Missouri, USA.
- Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
- Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
- Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
ORCID-Profile: Timothy McBride, Maria Baggstrom, Ying Liu
Förderung
- NIMHD NIH HHS
- NCI NIH HHS
- JG CDC HHS
- National Institute on Minority Health and Health Disparities
- Centers for Disease Control and Prevention
Zitieren
APA
Lian, M., McBride, T., Kozower, B., Baggstrom, M., & Liu, Y. (2026). Health Insurance Type and Lung Cancer Stage Shift Following Coverage of Screening. Health Services Research. https://doi.org/10.1111/1475-6773.70154
Vancouver
Lian M, McBride T, Kozower B, Baggstrom M, Liu Y. Health Insurance Type and Lung Cancer Stage Shift Following Coverage of Screening. Health Services Research. 2026. doi:10.1111/1475-6773.70154
BibTeX
@article{Lian2026,
author = {Lian, Min and McBride, Timothy and Kozower, Benjamin and Baggstrom, Maria and Liu, Ying},
title = {Health Insurance Type and Lung Cancer Stage Shift Following Coverage of Screening},
journal = {Health Services Research},
year = {2026},
doi = {10.1111/1475-6773.70154}
}
EUVIMED